Credit Suisse Ag Bio N Tech Se Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Bio N Tech Se stock. As of the latest transaction made, Credit Suisse Ag holds 40,292 shares of BNTX stock, worth $4.73 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

40,292

Previous 71,973 44.02%

Holding current value

$4.73 Million

Previous $7.6 Million 51.08%

% of portfolio

0.0%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$88.96 - $112.35 $2.82 Million - $3.56 Million	-31,681 Reduced 44.02%	40,292 $3.72 Million
Q4 2023 Feb 08, 2024	SELL	$90.91 - $112.75 $202,820 - $251,545	-2,231 Reduced 3.01%	71,973 $7.6 Million
Q3 2023 Nov 13, 2023	SELL	$98.5 - $125.08 $946,782 - $1.2 Million	-9,612 Reduced 11.47%	74,204 $8.06 Million
Q2 2023 Aug 11, 2023	BUY	$102.58 - $129.66 $1.6 Million - $2.02 Million	15,570 Added 22.81%	83,816 $9.05 Million
Q1 2023 May 10, 2023	BUY	$122.57 - $153.67 $4.48 Million - $5.62 Million	36,579 Added 115.51%	68,246 $8.5 Million
Q4 2022 Feb 13, 2023	SELL	$118.43 - $186.05 $3.85 Million - $6.04 Million	-32,479 Reduced 50.63%	31,667 $4.76 Million
Q3 2022 Nov 10, 2022	SELL	$127.65 - $183.11 $2.23 Million - $3.2 Million	-17,486 Reduced 21.42%	64,146 $8.65 Million
Q2 2022 Aug 12, 2022	SELL	$123.25 - $186.24 $2.51 Million - $3.79 Million	-20,373 Reduced 19.97%	81,632 $12.2 Million
Q1 2022 May 16, 2022	BUY	$126.25 - $231.85 $6.54 Million - $12 Million	51,803 Added 103.19%	102,005 $17.4 Million
Q4 2021 Feb 14, 2022	SELL	$216.64 - $362.52 $17.8 Million - $29.8 Million	-82,305 Reduced 62.11%	50,202 $12.9 Million
Q3 2021 Nov 12, 2021	BUY	$205.93 - $447.23 $16.4 Million - $35.5 Million	79,436 Added 149.68%	132,507 $36.2 Million
Q2 2021 Aug 16, 2021	BUY	$113.32 - $241.49 $1.66 Million - $3.54 Million	14,658 Added 38.16%	53,071 $11.9 Million
Q1 2021 May 14, 2021	SELL	$85.73 - $119.5 $14.8 Million - $20.6 Million	-172,150 Reduced 81.76%	38,413 $4.19 Million
Q4 2020 Feb 12, 2021	BUY	$72.71 - $129.54 $13.4 Million - $24 Million	184,896 Added 720.36%	210,563 $17.2 Million
Q3 2020 Nov 13, 2020	BUY	$57.81 - $104.17 $596,136 - $1.07 Million	10,312 Added 67.16%	25,667 $1.78 Million
Q2 2020 Aug 12, 2020	SELL	$38.58 - $66.74 $206,364 - $356,992	-5,349 Reduced 25.84%	15,355 $1.03 Million
Q1 2020 May 13, 2020	SELL	$28.55 - $92.0 $126,933 - $409,032	-4,446 Reduced 17.68%	20,704 $1.21 Million
Q4 2019 Feb 12, 2020	BUY	$12.75 - $36.91 $320,662 - $928,286	25,150 New	25,150 $852,000

Others Institutions Holding BNTX

# of Institutions

357

Shares Held

38.3M

Call Options Held

2.45M

Put Options Held

2.29M

View Full List

About BioNTech SE

Ticker BNTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 242,684,992
Market Cap $28.5B
Description
BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...

More about BNTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account